ClinicalTrials.gg
RecruitingNCT05911737Updated Jun 22, 2023

Ocular Parameters in Patients With Sleep Apnea

An observational study in Sleep Apnea Syndrome, Obstructive, Drowsiness and Blinking, sponsored by Democritus University of Thrace. Recruiting at 1 site in Greece. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-22.

Sponsored by Democritus University of Thrace · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Feb 2024, 2 years 9 months ago, but the record still lists the study as recruiting.
  • Started Jul 2022; still recruiting 4 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 17 studies in Sleep Apnea, Obstructive with a site in Greece — 3 open to participants now, 3 under way, none of them phase 3. Sleep Apnea, Obstructive · Greece.

Started
2022
the only one that year
Observational
8 of 17
3 open now
Registered
15th of 17
by date
Lead sponsor
1 of 17
Democritus University of Thrace

Among the 17 studies in Sleep Apnea, Obstructive with a site in Greece, this one is the only one that started in 2022, is one of 8 observational ones, and was the 15th registered.

Sleep Apnea, Obstructive

2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.

Browse Sleep Apnea, Obstructive studies →

Open to participants now

3 of the 17 studies in Sleep Apnea, Obstructive with a site in Greece are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Greece have not opened yet or have stopped. Only those recruiting at a site in Greece →

Who these studies take

Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 17 studies in Sleep Apnea, Obstructive with a site in Greece, or all of them as a file.
02

Study summary

The aim of this study is to assess the ocular parameters of drowsiness in patients with diagnosed Obstructive Sleep Apnea Syndrome through objective methods of ocular imaging and subjective evaluation methods (questionnaire)

Read the detailed description

This is a single-center prospective comparative observational study. One hundred patients with drowsiness that will be examined in the Sleep Clinic of Alexandroupolis University Hospital, aged between18-70 years old, with Distance Uncorrected Visual Acuity ≥ (dUVA): 5/10 will be recruited. They will be separated into two groups, one consisting of patients with diagnosed Obstructive Sleep Apnea and one without this diagnosis, according to the Epworth Sleepiness Scale - ESS, which is a valid tool for quantifying daily sleepiness. A 10-minute video in a foreign language (not English or Greek) with greek subtitles will be presented to them and a questionnaire will follow to assess the level of concentration during the video (the subtitles are crucial to understanding the video's plot). The video will be displayed in a 11.6" screen with resolution of 1920x1080 pixels, at 70 cm patient-to-screen distance. The patients' eyes will be recorded during the video with a Raspberry Pi Camera Module IR-CUT v2 (5MP,1080p) with 2 IR LED lights, connected to a Raspberry Pi 3 model v1.2, operating at the original resolution of 1080×1920, at 20 cm patient-to-camera distance and an algorithm will be developed to analyze the following parameters: 1. The complete and incomplete blinks defined by the "length of palpebral fissure-to-iris diameter" ratio, 3. Length of palpebral fissure of both eyes.

03

Conditions studied

  • Sleep Apnea Syndrome, Obstructive
  • Drowsiness
  • Blinking
  • Concentration Ability Impaired
  • Pupil Diameter

Keywords

  • Reading Time
  • Fixation
  • Saccadic movements
  • Eyelid margin distance
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

patients with obstructive sleep apnea and controls (not diagnosed with οbstructive sleep apnea)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients with obstructive sleep apnea and controls, aged 18-70 years old, with distance uncorrected visual acuity (dUVA) ≥ 5/10.

Exclusion criteria

Exclusion Criteria:

  • (dUVA) \<5/10,
  • intraocular pressure lowering medications
  • former corneal or fundus disease
  • neurological or psychiatric conditions
  • mental disability
  • difficulty reading
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients diagnosed with Obstructive Sleep Apnea

    Patients diagnosed with Obstructive Sleep Apnea

    Behavioral: Short video and Questionnaire

  • Patients not diagnosed with Obstructive Sleep Apnea

    Patients not diagnosed with Obstructive Sleep Apnea

    Behavioral: Short video and Questionnaire

Interventions

  • BehavioralShort video and Questionnaire

    A 10-minute video in a foreign language (not English or Greek) with greek subtitles will be presented and a questionnaire will follow to assess the level of concentration during the video

06

What researchers measure

Primary outcomes

  1. Total number of blinks during the 10-minute video

    The total number of blinks during the 10-minute video. Complete blinks are defined by the "length of palpebral fissure-to-iris diameter" ratio.

    Time frame: 1 week

  2. Total number of complete blinks during the 10-minute video

    The total number of complete blinks during the 10-minute video. Complete blinks are defined by the "length of palpebral fissure-to-iris diameter" ratio.

    Time frame: 1 week

  3. Total number of incomplete blinks during the 10-minute video

    The total number of incomplete blinks during the 10-minute video. Incomplete blinks are defined by the "length of palpebral fissure-to-iris diameter" ratio.

    Time frame: 1 week

  4. Number of total blinks for each minute

    Number of total blinks for each minute of the 10-minute video

    Time frame: 1 week

  5. Number of complete blinks for each minute

    Number of complete blinks for each minute of the 10-minute video

    Time frame: 1 week

  6. Number of incomplete blinks for each minute

    Number of incomplete blinks per minute for each minute of the 10-minute video

    Time frame: 1 week

  7. Total blinks per minute

    Total blinks per minute during the 10-minute video

    Time frame: 1 week

  8. Complete blinks per minute

    Complete blinks per minute during the 10-minute video

    Time frame: 1 week

  9. Incomplete blinks per minute

    Incomplete blinks per minute during the 10-minute video

    Time frame: 1 week

  10. Length of palpebral fissure of both eyes

    The distance between the upper eyelid margin and the lower eyelid margin (ie. the vertical dimension of the palpebral fissure) for each frame

    Time frame: 1 week

Secondary outcomes

  1. Fixations to the area of interest

    Number of fixations to the area of interest (subtitles)

    Time frame: 1 week

  2. Fixation duration

    Mean fixation duration (duration of fixation per video per participant)

    Time frame: 1 week

  3. Reading time

    The absolute reading time (the sum of the duration of all fixations and saccadic movements in the area of focus starting from the first fixation)

    Time frame: 1 week

  4. Participant's dedication time to the area of focus

    The percentage of time that each participant dedicates to the area of focus depending on the time of subtitle exposure (eg. subtitle reading time/overall subtitle exposure= 2500 msec/3000 msec=83%)

    Time frame: 1 week

  5. Rereadings

    Rereadings: the number of fixations/seccadic movements to the area of focus after the first reading (indicating of subtitlte interpretation difficulty or extended subtitle exposure time).

    Time frame: 1 week

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2022 (actual). Primary completion is estimated for Feb 2024, 19 months after the start.

Of 258 non-industry observational studies under Sleep Apnea, Obstructive, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 63. This study's planned 19 months is below that.

Counting every sponsor, half of 294 studies reached it within 29 months; a quarter within 14 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 10, 2023
First posted
Jun 22, 2023
StartActual
Jul 1, 2022
Primary completionEst.
Feb 1, 2024
CompletionEst.
Jul 1, 2024
Last update
Jun 22, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05911737
Lead sponsor
Democritus University of Thrace
Responsible party
Georgios Labiris (Professor (Associate) of Democritus University of Thrace, Democritus University of Thrace) — Principal investigator
First posted
Jun 22, 2023
Start date
Jul 1, 2022
Primary completion
Feb 1, 2024 (estimated)
Completion
Jul 1, 2024 (estimated)
Last update
Jun 22, 2023

Study contacts

Georgios Labiris, MD, PhD
Contact
labiris@usa.net
2551030405 ext. 0030
Georgios Labiris, MD, PhD
study chair · Democritus University of Thrace

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion